Found: 15
Select item for more details and to access through your institution.
Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 693, doi. 10.1111/bjh.18303
- By:
- Publication type:
- Article
Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 482, doi. 10.1111/bjh.17213
- By:
- Publication type:
- Article
Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 1, p. 141, doi. 10.1111/bjh.12339
- By:
- Publication type:
- Article
Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia patients transplanted by reduced intensity conditioning.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 4, p. 601, doi. 10.1111/ejh.14151
- By:
- Publication type:
- Article
Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 1, p. 3, doi. 10.1177/2040620715614529
- By:
- Publication type:
- Article
A novel RT-q PCR assay for quantification of the MLL- MLLT3 fusion transcript in acute myeloid leukaemia.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 5, p. 394, doi. 10.1111/ejh.12156
- By:
- Publication type:
- Article
The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
- Published in:
- European Journal of Haematology, 2009, v. 83, n. 5, p. 439, doi. 10.1111/j.1600-0609.2009.01309.x
- By:
- Publication type:
- Article
Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes.
- Published in:
- Case Reports in Hematology, 2018, p. 1, doi. 10.1155/2018/3726593
- By:
- Publication type:
- Article
Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission - methodologies in relation to their clinical situation.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 5, p. 569, doi. 10.1111/j.1365-2141.2012.09203.x
- By:
- Publication type:
- Article
Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 6, p. 782, doi. 10.1111/j.1365-2141.2008.07132.x
- By:
- Publication type:
- Article
Genetic and epigenetic similarities and differences between childhood and adult AML.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 4, p. 525, doi. 10.1002/pbc.23397
- By:
- Publication type:
- Article
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapy.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 690, doi. 10.1002/jha2.699
- By:
- Publication type:
- Article